About

Founded in 2001, Sihuan Pharmaceutical Group Holding has since grown into a leading pharmaceutical company in China’s prescription drug market. Some of its notable achievements include becoming the largest cardio-cerebral vascular drug franchise in China’s prescription drug market since 2007. The success of the Group can in part be attributed to its legal team who support the organisation’s extensive distribution network and diversified portfolio of market-leading drugs and research and development capabilities. With an emphasis set on training and furthering the expertise and skillset of the legal department, the legal team is transforming and developing within the business: ‘Through the general counsel, the team is growing and becoming more talented, professional and partnering with the business for a transformation of a Hong Kong listing company into a more open global group company’, says a member of the legal team. In recent years, the legal department has also assisted on a number of approvals in innovative drug trials granted by the CFDA.